Particle.news
Download on the App Store

Court Sets March Merits Trial as Paramount’s $111 Billion Warner Bros. Deal Stays Paused

A March trial will put state antitrust claims to the test, raising the prospect of billions in penalties for Paramount.

Overview

  • A federal judge scheduled a 12‑day merits trial to begin March 2, 2027, in the Northern District of California to decide the 12‑state Clayton Act suit seeking to block the merger.
  • Paramount agreed to delay closing until five days after the trial or June 1, 2027, a pause that increases exposure to accruing ticking fees and heightens pressure from contractual deadlines.
  • The state attorneys general allege the combined Paramount‑WBD would control roughly 27–30 percent of basic cable affiliate fees and wide‑release theatrical distribution, which they say would harm competition and consumers.
  • Paramount CEO David Ellison published an op‑ed arguing opponents are motivated by concerns over CNN and his politics and pledged newsroom independence while parallel suits from the WGA and shareholders press separate claims.
  • If the deal fails or is delayed past set deadlines Paramount faces large costs including a reported ticking fee that will begin in October and a potential $7 billion termination payment, and regulators in the EU and UK continue separate reviews that could shape the outcome and industry precedent.